109 related articles for article (PubMed ID: 32568240)
1. Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens.
Sharma S; Wright GJ
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568240
[TBL] [Abstract][Full Text] [Related]
2. Investigating Cellular Recognition Using CRISPR/Cas9 Genetic Screening.
Chong ZS; Wright GJ; Sharma S
Trends Cell Biol; 2020 Aug; 30(8):619-627. PubMed ID: 32595062
[TBL] [Abstract][Full Text] [Related]
3. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
[TBL] [Abstract][Full Text] [Related]
4. Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes.
Ihry RJ; Salick MR; Ho DJ; Sondey M; Kommineni S; Paula S; Raymond J; Henry B; Frias E; Wang Q; Worringer KA; Ye C; Russ C; Reece-Hoyes JS; Altshuler RC; Randhawa R; Yang Z; McAllister G; Hoffman GR; Dolmetsch R; Kaykas A
Cell Rep; 2019 Apr; 27(2):616-630.e6. PubMed ID: 30970262
[TBL] [Abstract][Full Text] [Related]
5. Pooled CRISPR-Based Genetic Screens in Mammalian Cells.
Chan K; Tong AHY; Brown KR; Mero P; Moffat J
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31545321
[TBL] [Abstract][Full Text] [Related]
6. Key elements for designing and performing a CRISPR/Cas9-based genetic screen.
Shang W; Wang F; Fan G; Wang H
J Genet Genomics; 2017 Sep; 44(9):439-449. PubMed ID: 28967615
[TBL] [Abstract][Full Text] [Related]
7. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
[TBL] [Abstract][Full Text] [Related]
8. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
9. Genetic dissection of mammalian ERAD through comparative haploid and CRISPR forward genetic screens.
Timms RT; Menzies SA; Tchasovnikarova IA; Christensen LC; Williamson JC; Antrobus R; Dougan G; Ellgaard L; Lehner PJ
Nat Commun; 2016 Jun; 7():11786. PubMed ID: 27283361
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute.
Wang B; Wang M; Zhang W; Xiao T; Chen CH; Wu A; Wu F; Traugh N; Wang X; Li Z; Mei S; Cui Y; Shi S; Lipp JJ; Hinterndorfer M; Zuber J; Brown M; Li W; Liu XS
Nat Protoc; 2019 Mar; 14(3):756-780. PubMed ID: 30710114
[TBL] [Abstract][Full Text] [Related]
11. Application of CRISPR genetic screens to investigate neurological diseases.
So RWL; Chung SW; Lau HHC; Watts JJ; Gaudette E; Al-Azzawi ZAM; Bishay J; Lin LT; Joung J; Wang X; Schmitt-Ulms G
Mol Neurodegener; 2019 Nov; 14(1):41. PubMed ID: 31727120
[TBL] [Abstract][Full Text] [Related]
12. Pooled Genome-Scale CRISPR Screens in Single Cells.
Schraivogel D; Steinmetz LM; Parts L
Annu Rev Genet; 2023 Nov; 57():223-244. PubMed ID: 37562410
[TBL] [Abstract][Full Text] [Related]
13. Application of CRISPR screens to investigate mammalian cell competition.
Paraskevopoulos M; McGuigan AP
Brief Funct Genomics; 2021 Jun; 20(3):135-147. PubMed ID: 33782689
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
Thomsen EA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
[TBL] [Abstract][Full Text] [Related]
15. Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.
Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Persaud SJ; Amisten S
Cell Physiol Biochem; 2018; 45(2):656-666. PubMed ID: 29408822
[TBL] [Abstract][Full Text] [Related]
16. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.
Lin G; Zhang K; Peng R; Han Y; Xie J; Li J
J Mol Diagn; 2018 May; 20(3):373-380. PubMed ID: 29680088
[TBL] [Abstract][Full Text] [Related]
17. Large-Scale Single Guide RNA Library Construction and Use for CRISPR-Cas9-Based Genetic Screens.
Wang T; Lander ES; Sabatini DM
Cold Spring Harb Protoc; 2016 Mar; 2016(3):pdb.top086892. PubMed ID: 26933254
[TBL] [Abstract][Full Text] [Related]
18. [CRISPR/Cas9 SAM (synergic activation mediator): a new strategy to screen for genome-encoded antiviral restriction factors].
Dekeyzer B; Hoareau M; Laghlali G
Med Sci (Paris); 2018 May; 34(5):401-403. PubMed ID: 29900840
[No Abstract] [Full Text] [Related]
19. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 as a Genome Editing Tool for Targeted Gene Integration in CHO Cells.
Sergeeva D; Camacho-Zaragoza JM; Lee JS; Kildegaard HF
Methods Mol Biol; 2019; 1961():213-232. PubMed ID: 30912048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
